Physician profile
Paul A Thomas
NPI 1720077910
$3,654.36
in general payments reported to CMS, 2019-2025
16 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,765 · 2020: $119 · 2021: $1,336 · 2022: $146 · 2023: $34.96 · 2024: $82.54 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $2,686.12 | 2019-2021 | |
| Stryker Corporation | $489.83 | 2019-2022 | |
| Bioventus LLC | $104.07 | 2025 | Exogen Ultrasound Bone Healing System, Xcell, Durolane |
| Pacira Pharmaceuticals Incorporated | $102.53 | 2020-2021 | |
| Axogen | $45.93 | 2020 | |
| Djo, LLC | $36.05 | 2025 | Donjoy |
| Integra Lifesciences Corporation | $34.96 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $27.22 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $24.40 | 2024 | Monovisc |
| Fidia Pharma USA INC. | $16.35 | 2025 | Hymovis |
| Innovation Technologies INC | $16.26 | 2024 | Irrisept |
| Amgen INC. | $14.95 | 2025 | Krystexxa |
| Novo Nordisk INC | $14.66 | 2024 | Rybelsus, Ozempic |
| Pfizer INC. | $14.63 | 2020 | |
| Smith+Nephew, INC. | $14.07 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.